Table 5.: How would you rate the level of protection offered
by Proton Pump Inhibitors (PPIs) for the upper and
lower GI tract where one is ‘no protection at all’ and
10 is ‘very high level of protection. A summary of
those who scored an 8 or above is provided in the
table below.
Country/Cohort Considered
Upper GI Tract %
Lower GI Tract %
Total Cohort
68
21
France
57
16
Germany
66
14
Italy
69
15
Spain
78
32
UK
59
14
Switzerland
78
12
Belgium
64
12
Portugal
77
43
Survey answers based on a total sample of n=704 primary care physicians. Sample of
approximately 100 physicians from all markets except Switzerland and Belgium
(sample size approximately 50 physicians).